Immunology: Safety and efficacy testing of a novel multivalent bovine bacterial respiratory vaccine composed of five bacterins and two immunogens

DOI Web Site Web Site 参考文献32件
  • CHO Yun Sang
    Bacteriology and Parasitology Division, Animal Disease Research Department, National Veterinary Research & Quarantine Service
  • LEE Hee Soo
    Bacteriology and Parasitology Division, Animal Disease Research Department, National Veterinary Research & Quarantine Service
  • LIM Sook-Kyoung
    Bacteriology and Parasitology Division, Animal Disease Research Department, National Veterinary Research & Quarantine Service
  • JOO Yi-Seok
    Bacteriology and Parasitology Division, Animal Disease Research Department, National Veterinary Research & Quarantine Service
  • KIM Jong Man
    Bacteriology and Parasitology Division, Animal Disease Research Department, National Veterinary Research & Quarantine Service
  • KIM Jae Hoon
    Veterinary Pathology Laboratory, Cheju National University

書誌事項

タイトル別名
  • Safety and Efficacy Testing of a Novel Multivalent Bovine Bacterial Respiratory Vaccine Composed of Five Bacterins and Two Immunogens

この論文をさがす

抄録

Bovine bacterial respiratory diseases have been one of the most serious problems due to their high mortality and economic loss in calves. The vaccinations of bovine bacterial respiratory vaccines have been complex because of no multivalent vaccine. In this study, novel multivalent bovine bacterial respiratory vaccine (BRV) was developed and tested for its safety and efficacy. BRV was composed of two immunogens and five bacterins. These were leukotoxoid and bacterin of Mannheimia haemolytica type A, outer membrane protein and bacterin of Pasteurella multocida type A, and bacterins of Haemophilus somnus, Mycoplasma bovis, and Arcanobacterium pyogenes. ELISA antibody titers to five bacterial antigens in vaccinated guinea pigs increased, compared with those in unvaccinated ones. BRV was safe for calves and pregnant cattle in this study. In calves challenged with M. haemolytica and P. multocida, the average daily weight gain and antibody titers of vaccinated calves increased, and respiratory symptoms (P<0.05) and treatment frequency (P<0.01) of vaccinated calves significantly decreased, compared with those of unvaccinated calves. Interestingly, the antibody titers of M. haemolytica leukotoxoid and Mycoplasma bovis were closely related with the reduction of respiratory symptoms. BRV would be an ecomonical measure for the protection against bovine bacterial respiratory diseases.<br>

収録刊行物

参考文献 (32)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ